Improving laboratory results turnaround time.

K S Rudat; J Henry; J Mosley

PubMed · 9192596

Improving laboratory results turnaround time.

Abstract

BACKGROUND: Physicians need prompt results of laboratory tests before early morning rounds or on a stat basis to support time-critical decisions that can impact patient care or length of stay. At The Methodist Hospital, we formed a multidisciplinary performance improvement team that was successful in reducing the length of time between collection of specimen and availability of laboratory test results (turnaround time). Our goals were to have Stat results available in less than 60 minutes, and results for morning blood tests available by 8 AM for acute care units and 7 AM for critical care units. METHODS: Before making changes, we first devised a system of measurement. The most efficient way to obtain data was to query the mainframe laboratory information system for times of specimen collection, times for reception in the laboratory, and times for results verification. We also decided that patient-specific information on specimens that did not meet the goals-exceptions-would be crucial for effective follow-up and corrective action. During several measurement and assessment cycles, we identified opportunities to improve our process. RESULTS: The percentage of early morning specimens meeting the specified turnaround time improved from 60% in August 1995, to greater than 90% in May 1996. The average turnaround time for early morning specimens takes only 95 minutes rather than 186 minutes. The average turnaround time for a stat specimen declined from 69 minutes to 45 minutes during this process. The volume of stat specimens has also declined significantly. CONCLUSION: Laboratory test results turnaround time is impacted by a variety of health-care providers, and a multidisciplinary team can work together to improve prompt availability of test results to support time-critical decisions.

Explore related subjects

Humans Laboratories, Hospital Management Quality Circles Medical Laboratory Personnel Process Assessment, Health Care Professional Staff Committees Texas Time Management Total Quality Management Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

K S Rudat, J Henry, J Mosley. Improving laboratory results turnaround time.. https://pubmed.ncbi.nlm.nih.gov/9192596/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2027

Global Genomic Surveillance.

Global genomic surveillance has emerged as a foundational pillar of public health in the twenty-first century, enabling real-time tracking of pathogen evolution and informing outbreak response. This chapter examines the strategic architecture of global genomic surveillance, focusing on its application to arboviruses such as chikungunya virus (CHIKV). It explores the integration of genomic data with epidemiological, clinical, and environmental information within a One Health framework, while addressing critical challenges in governance, equity, and interoperability. The discussion covers the entire genomic surveillance workflow, from sample collection and sequencing to bioinformatic analysis and phylogenetic inference, and highlights the transformative role of artificial intelligence (AI) in predictive surveillance. By analyzing global initiatives, operational barriers, and emerging technologies, this chapter underscores the necessity of sustainable, equitable, and interoperable genomic systems to proactively address current and future infectious disease threats.

Humans↗

PubMed2027

Systematic Dissection of Key Driver Perturbation Signatures in Single Cells via ECCITE-seq.

CRISPR screens, such as expanded CRISPR-compatible cellular indexing of transcriptomes and epitopes by sequencing (ECCITE-seq), enable the simultaneous measurement of transcriptomes, gRNA identity, and cell-surface protein expression at single-cell resolution to systematically interrogate gene function. This platform provides a powerful and scalable experimental approach for validating disease-associated regulators identified by large-scale association studies and other computational methods, including network-based analyses of multi-omics data. Here, as an example application, we describe an ECCITE-seq framework to characterize the transcriptomic consequences of perturbing multiple neuronal key driver genes associated with Alzheimer's disease (AD) in human-induced pluripotent stem cell (hiPSC)-derived neurons. More broadly, by integrating customized pooled gRNA libraries with different CRISPR effectors across multiple cell types, this approach allows for the assessment of the regulatory impact of candidate genes implicated in development and disease processes.

Humans↗

PubMed2027

Identification of Genome-Wide Chromatin Structural Aberration in Cancer by Hi-C Analysis.

Aberrant three-dimensional genome organization is a hallmark of cancer, often driving oncogene activation through mechanisms such as enhancer hijacking. High-throughput chromosome conformation capture (Hi-C) maps these interactions on a genome-wide scale. Unlike earlier dilution-based methods, in situ Hi-C performs proximity ligation within intact nuclei, minimizing random ligation noise and enabling fine-scale structure detection. This chapter describes an optimized in situ Hi-C protocol tailored for cancer cell lines using MboI digestion and biotin-mediated pull-down to generate high-complexity libraries. We further outline a computational workflow that extends beyond standard topological mapping of compartments and topologically associating domains to identify cancer-specific aberrations. Specifically, we focus on detecting chromosomal rearrangements (structural variants) and characterizing the distinct circular topology of extrachromosomal DNA. This integrated experimental and analytical framework provides the necessary tools to dissect the spatial dysregulation underlying tumor evolution.

Humans↗